Joanna Poutou

Ottawa Hospital — Canada

Biochemistry, Genetics and Molecular Biology · Life Sciences

13h-index472citations31works8.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(15), SARS-CoV-2 and COVID-19 Research(12), Viral Infectious Diseases and Gene Expression in Insects(7), CAR-T cell therapy research(6), RNA Interference and Gene Delivery(5)

Publications31 total

Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic viruses
Nature Biomedical Engineering·2024· 5 cited
Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy
Nature Communications·2024· 12 citedOpen Access
A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection
Molecular Therapy — Methods & Clinical Development·2023· 11 citedOpen Access
Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy
Pharmaceuticals·2023· 8 citedOpen Access
Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment
Frontiers in Immunology·2023· 12 citedOpen Access
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy
Nature Communications·2022· 46 citedOpen Access
Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection
Molecular Therapy·2021· 23 citedOpen Access
Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter
Journal of Visualized Experiments·2021
Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter
Journal of Visualized Experiments·2021· 2 cited
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Journal of Visualized Experiments·2021
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Journal of Visualized Experiments·2021
A High-Throughput NanoBiT-Based Serological Assay Detects SARS-CoV-2 Seroconversion
Nanomaterials·2021· 11 citedOpen Access
Characterization of Critical Determinants of ACE2–SARS CoV-2 RBD Interaction
International Journal of Molecular Sciences·2021· 32 citedOpen Access
Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry
Molecular Therapy·2021· 26 citedOpen Access
Characterization of Critical Determinants of ACE2-RBD Interaction
2021Open Access
Redirecting oncolytic viruses: Engineering opportunists to take control of the tumour microenvironment
Cytokine & Growth Factor Reviews·2020· 10 cited
Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization
Membranes·2020· 24 citedOpen Access
Nanoluciferase complementation-based biosensor reveals the importance of N- linked glycosylation of SARS-CoV-2 Spike for viral entry
2020· 6 citedOpen Access
Inhibition of adenovirus infection by mifepristone
Antiviral Research·2018· 26 citedOpen Access
Adaptation of vectors and drug-inducible systems for controlled expression of transgenes in the tumor microenvironment
Journal of Controlled Release·2017· 11 cited
page 1 of 2Next →

Frequent Co-authors

Carolina S. Ilkow(18), Taha Azad(16), Taylor R. Jamieson(15), Mathieu J. F. Crupi(12), Ragunath Singaravelu(12), John C. Bell(12), Reza Rezaei(11), Jean‐Simon Diallo(11), Zaid Taha(10), Abera Surendran(9), Rubén Hernández-Alcoceba(9), Stephen Boulton(9), Bradley Austin(8), Nikolas T. Martin(8), Adrian Pelin(7), Julia Petryk(7), María Buñuales(7), Ricardo Marius(7), Jaahnavi Dave(5), Sarah Tucker(5)